
Prevencio, Inc.: A US-based life science company developing diagnostic and prognostic products for cardiology.
Prevencio, Inc., founded with the mission to revolutionize cardiovascular health, is a US-based life science company focused on developing advanced diagnostic and prognostic products. The company leverages AI-powered blood tests to provide early detection and prevention of cardiovascular diseases, aiming to reduce unnecessary procedures and their associated side effects. Prevencio's core market includes emergency rooms, cardiology clinics, and clinical laboratories across the United States.
Notable individuals affiliated with Prevencio include experts in cardiology and biotechnology, contributing to the company's innovative approach. Prevencio has garnered attention for its cutting-edge technology and has been featured in prominent medical publications. Its key achievements include the development of personalized blood tests that significantly enhance early detection of heart disease and stroke, thereby making a substantial impact on patient outcomes and healthcare efficiency.

Predictive Health Diagnostics Company

Preventric

Preventa Medical

Pr3vent
pr3vent.com

Prolocor
prolocor.com

Previse
previsedx.com

Precede Biosciences
precede.bio

Prevacept Infection Control
Cardio Diagnostics Holdings

PreventScripts

PulseData
pulsedata.io

Arterial Health International

Covanos
covanos.com

Prevention Pharmaceuticals

Prevacus
Companies similar to Prevencio include Predictive Health Diagnostics Company, Preventric, Preventa Medical and Pr3vent.
Prevencio was founded in 2006.
Prevencio's headquarters is located in Kirkland, WA, US.
Prevencio's most recent funding round was for $4M (USD) in November 2017.
As of Nov 14, 2017, Prevencio has raised a total of $11M (USD).
Prevencio has 9 employees as of Feb 5, 2024.